Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetir Plc Regulatory News (MET)

Bob Moore, Chairman and CEO, explains how Metir (AIM:MET) is set to transform water safety

Bob Moore, Chairman and CEO, explains how Metir (AIM: MET) is set to transform water safety

Share Price Information for Metir Plc (MET)

Share Price is delayed by 15 minutes
Get Live Data
0.80    -0.05 (-5.88%)
Bid:
0.75
Ask:
0.85
Spread: 0.10 (13.333%)
Market Cap: £3.55m
MET Live PriceLast checked at - London Stock Exchange

Intraday Metir Plc Share Chart

Trading Update and Growth Plan

2 Dec 2025 07:00

RNS Number : 7826J
Metir PLC
02 December 2025
 

2 December 2025

Metir plc

 

("Metir", the "Group" or the "Company")

 

Trading Update and Growth Plan

 

Metir plc (AIM: MET), the leading global provider of fast response mobile and point-of-use water and environmental testing technology, today provides a trading update ahead of its financial year ended 31 December 2025.

 

Trading and order book

 

The Group has continued to build on the significant progress reported in its Interim Results on 30 September 2025. Demand is increasing, driven by growing international demand for Microtox® LX instruments, reagents and SRB sales.

 

Customer demand for LX instruments has been encouraging, and sales are in line with management expectations as reported in September 2025. Although production rates of instruments have increased during the second half of the year, the Group is nearing the limits of its current outsourced manufacturing capacity. 

 

Metir believes that it can secure materially higher sales volumes of instruments if it can increase the build and supply rate. The Group is in discussions with its manufacturing partner to increase production rates in 2026. This will both reduce delivery times for larger batches made to order for specific customers and simultaneously create a stock of instruments which can be used to meet short turnaround demand. The growing customer base of LX and FX instruments drives demand for high-margin Microtox® reagents, but unlocking and accelerating this high-margin growth depends on scaling LX and FX unit production reliably.

 

As part of the Group's growth strategy, Metir also intends to further upgrade the LX and FX units with upgraded and easily sourced supply chain components in 2026. This will significantly improve instrument margins by facilitating increased and reliable manufacturing output.

 

Sales of Sulphate Reducing Bacteria (SRB) kits, which started in June 2025, give the fastest results available on the market, remain robust and are in high demand. Orders of SRB kits have increased, with customer interest rising and quotations given to over 60 companies worldwide. Again, with manufacturing nearing capacity, a key component of the kits had to be paused in Q4 for necessary upgrades to improve the reliability and efficiency of the manufacturing process to increase volumes. This will enable the Group to maximise sales of this high-margin product in January 2026, providing considerable revenue contribution.

 

Qatar project and GCC regional development

 

On 26 September 2025, Metir reported it had completed the final commissioning of the 27 CTM units in Qatar. Since then, a small number of instruments have given technical challenges, which are being solved quickly by the Group working through its partner Avanceon. Consequently, Metir has agreed a deferred payment schedule with Avanceon for the remaining £198k with payment due by the end of Q1 2026. This will enable an additional contract performance payment of £50k to be due during the same period.

 

The majority of the installations are fully operational, and replacement reagents will be routinely supplied by Metir to allow for continuous monitoring. Due to this installation in Doha being the first major state-operated system and an important proof-of-principle site for future large-scale projects, an initial supply of reagents in Qatar is included in the contract specification with new reagent revenue expected to start during early 2027.

 

During mid November 2025, Metir took part in a UK-backed trade mission to the Kingdom of Saudi Arabia (KSA), engaging with government-linked organisations responsible for major national water programmes. KSA has the world's largest potable water desalination capacity and has committed US$105bn to 3,300 new water projects under its Vision 2030 programme, creating one of the world's largest markets for advanced water-safety technologies. Metir is establishing a marketing team, in conjunction with our regional installation partner Avanceon, based in Riyadh, to capitalise on KSA market opportunities for real-time screening for toxins in potable desalinated water.

 

Metir has also secured space on the UK Trade Pavilion at the forthcoming IFAT exhibition in Riyadh from 26-28 January 2026. IFAT is the leading regional water and waste management event and conference, with the Trade Pavilion supported by the UK Department of Business and Trade.

 

Growth and working capital

 

The Group's cash balance as of 1 December 2025 is £147k, which is slightly lower than forecast. The Group has been investing in increased manufacturing and additional payments made to our manufacturer for components required for the next batch build of LX instruments. Excluding invoices to be issued for additional LX instruments being shipped in December, current receivables are £317k. Given the invoiced sales and forecasts, the Group is comfortable that it has sufficient projected revenue and cash resources for the foreseeable future.

 

The Board considers investment in manufacturing and product development as essential. This is consistent with the Group's strategy to grow revenue streams from existing product lines while conducting near-term investment in product and supply chain enhancement to support long-term revenue and profit growth. With a new business development function recently hired, Metir is expanding its international distributor network and build on the success currently being experienced in Qatar for further CTM installations.

 

Bob Moore, Executive Chairman and Chief Executive Officer of Metir plc, commented:

 

"I am proud of our talented team and the progress Metir has achieved so far this year. The increased customer demand has exceeded management expectations. Looking ahead to 2026, Metir will enter the year with strong momentum in instrument sales, an expanding international footprint of installed instruments, and enhanced sales and customer support capability.

 

The Group is also seeing continued growth across Microtox® reagents and SRB product lines. Our validated technology platforms, scalable recurring-revenue model and expanding distributor network provide a solid platform for accelerated growth. Scaling manufacturing capacity is now mission-critical to meet customer demand and convert our strong commercial pipeline into revenue.

 

The Board considers 2026 as transformational and a pivotal year for growth. The Group retains the characteristics of an agile, entrepreneurial technology company, with world-class products and a pipeline of unique innovative technologies under development. The Group has invested in manufacturing growth and product development which includes use of proceeds of the successful June 2025 fund raise. Accordingly, EBITDA profitability is likely to be deferred until 2026 given our planned investment profile.

 

Against a backdrop of tightening global regulation, rising water scarcity and increasing need for real-time monitoring, Metir is a global leader in fast-response environmental testing technologies."

 

- Ends -

 

Enquiries:

 

Metir plc

Bob Moore, Executive Chairman and Chief Executive Officer

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets(Nominated Adviser & Joint Broker)

Alex Bond / Oliver Platts

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andrew Thacker / Guy McDougall 

+44 (0) 20 3657 0050

 

Northstar Communications (Investor Relations)

Sarah Hollins

+44 (0) 113 730 3896

 

About Metir

 

Metir plc is a leading global provider of fast response, mobile and point-of-use water and environmental testing technology. Through its two established trading divisions, Modern Water and Microsaic Systems a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.

 

With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.

 

Headquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.

 

For more information, please visit: https://www.metirplc.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFAFEDESFAA
Date   Source Headline
4th Jun 20267:00 amRNSMajor Commercial Advances for PFAS Platform
20th Apr 20267:00 amRNSAppointment of Three New Distributors
25th Mar 20267:00 amRNSContinuous Toxicity Monitoring Project Update
24th Feb 20267:00 amRNS-RInvestor Webinar
17th Feb 20267:00 amRNSTechnical Feasibility for Pathogen Detector
16th Feb 20268:53 amRNSHolding(s) in Company
16th Feb 20268:52 amRNSHolding(s) in Company
16th Feb 20268:52 amRNSHolding(s) in Company
10th Feb 20267:00 amRNSAppointment of Nominated Adviser
13th Jan 20267:00 amRNSTrading Statement
22nd Dec 20257:00 amRNSFundraise
2nd Dec 20257:00 amRNSTrading Update and Growth Plan
19th Nov 20257:00 amRNSCFO Appointment
4th Nov 20257:00 amRNS-RAdvancement of PFAS detection technology
30th Sep 20257:00 amRNSHalf-year Report
26th Sep 20257:00 amRNSFinal Commissioning of Qatar Project
11th Sep 20257:00 amRNSNew Contract with Aptamer Group
12th Aug 202512:30 pmRNSResult of AGM
31st Jul 20257:00 amRNSInterim Trading Update
21st Jul 20259:23 amRNSDirector Participation in Fundraising & TVR
11th Jul 20257:00 amRNSNotice of AGM & Posting of Annual Report
10th Jul 20252:30 pmRNSRestoration - Metir PLC
10th Jul 20252:30 pmRNSFinal Results
4th Jul 20254:16 pmRNSUpdate re. Publication of Annual Report & Accounts
1st Jul 20257:30 amRNSSuspension - Metir PLC
30th Jun 20254:53 pmRNSPublication of Annual Report & Accounts
25th Jun 202512:33 pmRNSHolding(s) in Company
24th Jun 202511:06 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSFundraise
29th May 20257:00 amRNSTrading Update
13th May 20259:15 amRNSHolding(s) in Company
31st Mar 20257:00 amRNSOperational Update
2nd Sep 201411:02 amRNSResult of EGM
7th Aug 201410:53 amRNSProposed Cancellation of Trading on AIM
31st Jul 20147:00 amRNSProposed cancellation of admission to trade on AIM
23rd Jul 20143:40 pmRNSHolding(s) in Company
23rd Jul 201411:20 amRNSResult of AGM
15th Jul 201412:06 pmRNSHolding(s) in Company
15th Jul 20147:30 amRNSSuspension - Metro Baltic Horizons Plc
14th Jul 20143:57 pmRNSProposed Cancellation of Trading on AIM
30th Jun 20142:13 pmRNSNotice of AGM & posting of Accounts replacement
30th Jun 20147:00 amRNSNotice of AGM & posting of Financial Statements
20th Jun 20149:03 amRNSFinal Results
13th Jun 20141:56 pmRNSPreliminary Results Update
9th May 20145:27 pmRNSHolding(s) in Company
9th May 20143:25 pmRNSProposed Suspension of Trading and delisting
6th May 20143:15 pmRNSSettlement Agreement reached with former Auditors
28th Mar 201410:13 amRNSSettlement Agreement
17th Oct 201311:13 amRNSHolding(s) in Company
10th Oct 20133:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.